MICHAEL F KANAN
CIK 1461953 · See Remarks · last filed 2019-03-11
MICHAEL F KANAN is a corporate insider who has filed 26 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for AVDL, was dated Mar 11, 2019. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
26
-$1.36M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | See Remarks | 50,538 | $21.64 | $1.09M | -$9.8K | 5 | 2019-03-11 |
| AVADEL PHARMACEUTICALS PLC (FLML) Delisted | See Remarks | 0 | — | — | $0 | 4 | 2017-01-03 |
| SIGMA ALDRICH CORP (SIAL) Delisted | VP & Corporate Controller | 6,912 | — | — | -$1.35M | 17 | 2015-11-19 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-11 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2018-12-18 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Sell (S) | −8,429 | -$21.0K | EDGAR |
| 2018-06-29 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +1,967 | $11.2K | EDGAR |
| 2017-12-14 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2017-01-13 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2017-01-03 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Disp (D) | −18,000 | $0 | EDGAR |
| 2017-01-03 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2016-12-16 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2016-12-16 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2015-11-19 | SIGMA ALDRICH CORP (SIAL) Delisted | Mixed | −7,700 | -$1.33M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.